Germany’s Medical Cannabis Crackdown: Warken’s Restrictions Meet Market Reality
Germany’s medical cannabis landscape is facing a dramatic regulatory shift as Health Minister Nina Warken (CDU) moves to reverse the liberal policies implemented by her predecessor Karl Lauterbach (SPD). The proposed restrictions come at a time when Germany has established itself as the world’s largest medical cannabis market, creating a striking contradiction between policy tightening […]
“Far too much for personal use” – What Germany’s Drug Commissioner is really saying (and what the politics behind it look like)
Germany’s new Federal Drug Commissioner, Hendrik Streeck (CDU), has once again placed the country’s cannabis rules under scrutiny. In an interview he argued the law is “not consistent and coherent,” pointing directly to the allowance of three home-grown plants per adult. Under the right conditions, he suggested, such a harvest could amount to up to […]
High Tide x Remexian: A Clear Signal—and a Stress Test—for Germany’s Medical Cannabis Market
High Tide’s decision to acquire 51% of Remexian Pharma for a preliminary €27.2 million isn’t just another headline; it’s a calculated entry into Europe’s largest medical cannabis market with a player that already moves real volume and runs a fully certified EU-GDP warehouse. The agreement includes an option to buy the remaining stake and is […]
Click-to-Get Cannabis Prescriptions? Now German Pharmacies Face Legal Heat
For years, the assumption in the German cannabis market was clear: if a prescription came through an online platform — usually operated from abroad — the risk lay with the telemedicine provider, not the pharmacy. That legal comfort zone has now been shattered. A new legal opinion commissioned by the Association of Cannabis Dispensing Pharmacies […]
Germany Pushes Back on Online Cannabis Prescriptions – A Turning Point for Telemedicine Startups?
The pressure is rising. On Tuesday, the Federal Chamber of Pharmacists (BAK) issued a formal resolution criticizing the increasing number of medical cannabis prescriptions issued through online platforms without personal doctor-patient contact. The move reflects a growing political and professional backlash against digital prescription models that operate with minimal diagnostic effort. According to the resolution, […]
BMG: Booming Demand for Medical Cannabis Alarms New German Health Minister
Nina Warken criticizes online prescriptions and signals stricter rules – but the growing demand also presents opportunities Since Germany partially legalized cannabis in April 2024, not only has recreational consumption increased — the medical cannabis market is also booming. Now, newly appointed Federal Health Minister Nina Warken (CDU) warns of “clear abuse” in the online […]
The Last Hurdle Fallen: Cannabis Cultivation Associations on the Rise in Germany
With the recent approval of cannabis cultivation associations in Bavaria, a significant political barrier has now been removed, allowing these associations to officially begin their operations. What was once considered nearly unimaginable has now become reality, marking another step toward the full legalization of cannabis in Germany. Bavaria has now approved its first non-commercial cannabis […]
Green Light for Cannabis Startups: Germany’s Legal Framework Remains Stable Until Fall Evaluation
Despite political pressure from Bavaria’s CSU, the recently formed coalition between Germany’s CDU/CSU and SPD has not included a reversal of the country’s partial cannabis legalization in its coalition agreement. This development signals continued stability for cannabis clubs and startups—at least until the scheduled law evaluation this autumn. A Political Tug of War Ends in […]
One Year After Cannabis Legalization in Germany: Political Turmoil and a Possible Rollback
Today, cannabis is dominating the headlines in Germany – and for good reason: Exactly one year ago, the country’s partial legalization law came into effect, marking a bold step toward modern drug policy. International observers saw Germany as a pioneer in Europe. But just twelve months later, the political tide is turning. As coalition negotiations […]
Germany does not need to wait for evaluation – data from Canada speaks clearly
The CDU argues that a cannabis evaluation is necessary before making a final decision. However, Canada’s experience already provides comprehensive evidence. Studies show that legalization there has neither worsened the black market nor weakened youth protection. Instead, cannabis-related arrests have decreased, and the market has been successfully regulated. Germany can learn from Canada’s successes and […]